Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Professional Survey Report 2016

June 2016 | 168 pages | ID: G61AEC6E332EN
QYResearch

Abstracts

This report

Mainly covers the following product types

• Non-glycosylated
• Glycosylated
• Others

The segment applications including

• Hospital use
• Clinic use
• Others

Segment regions including (the separated region report can also be offered)

• North America
• Europe
• Japan
• China
• Southeast Asia
• India

The players list (Partly, Players you are interested in can also be added)

• Jiangsu Wuzhong Pharma
• Johnson & Johnson
• Kyowa Hakko Kirin Co.,Ltd.
• Intas Pharmaceuticals
• Beijing Sihuan
• Qilu Pharma
• Shandong Kexing
• Teva Pharmaceutical
• CSPC Baike
• Oversease Manufacturer Company
• Shenzhen Xinpeng
• Beijing Sihuan
• Xiamen Tebao
• NCPC Jintan
• Beijing Shuanglu

With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Bottle and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Bottle, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Contents

1 INDUSTRY OVERVIEW OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION

1.1 Definition and Specifications of Recombinant Human Granulocyte Colony-stimulating Factor Injection
  1.1.1 Definition of Recombinant Human Granulocyte Colony-stimulating Factor Injection
  1.1.2 Specifications of Recombinant Human Granulocyte Colony-stimulating Factor Injection
    1.1.2.1 0.3ml:75ug
    1.1.2.2 0.6ml:150ug
    1.1.2.3 1.2ml:300ug
1.2 Classification of Recombinant Human Granulocyte Colony-stimulating Factor Injection
  1.2.1 Non-glycosylated
  1.2.2 Glycosylated
  1.2.3 Others
1.3 Applications of Recombinant Human Granulocyte Colony-stimulating Factor Injection
  1.3.1 Hospital use
  1.3.2 Clinic use
  1.3.3 Others
1.4 Industry Chain Structure of Recombinant Human Granulocyte Colony-stimulating Factor Injection
1.5 Industry Overview and Major Regions Status of Recombinant Human Granulocyte Colony-stimulating Factor Injection
  1.5.1 Industry Overview of Recombinant Human Granulocyte Colony-stimulating Factor Injection
  1.5.2 Global Major Regions Status of Recombinant Human Granulocyte Colony-stimulating Factor Injection
1.6 Industry Policy Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection
1.7 Industry News Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION

2.1 Raw Material Suppliers and Price Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection
2.2 Equipment Suppliers and Price Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection
2.3 Labor Cost Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection
2.4 Other Costs Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection
2.5 Manufacturing Cost Structure Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection
2.6 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION

3.1 Capacity and Commercial Production Date of Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Major Manufacturers in 2015

4 GLOBAL RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Capacity and Growth Rate Analysis
  4.2.2 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales and Growth Rate Analysis
  4.3.2 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Price
  4.4.2 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Recombinant Human Granulocyte Colony-stimulating Factor Injection Gross Margin
  4.5.2 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Gross Margin Analysis (Company Segment)

5 RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION REGIONAL MARKET ANALYSIS

5.1 North America Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Analysis
  5.1.1 North America Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Overview
  5.1.2 North America 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Price Analysis
  5.1.4 North America 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Share Analysis
5.2 Europe Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Analysis
  5.2.1 Europe Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Overview
  5.2.2 Europe 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Price Analysis
  5.2.4 Europe 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Share Analysis
5.3 Japan Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Analysis
  5.3.1 Japan Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Overview
  5.3.2 Japan 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Japan 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Price Analysis
  5.3.4 Japan 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Share Analysis
5.4 China Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Analysis
  5.4.1 China Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Overview
  5.4.2 China 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 China 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Price Analysis
  5.4.4 China 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Share Analysis
5.5 Southeast Asia Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Analysis
  5.5.1 Southeast Asia Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Overview
  5.5.2 Southeast Asia 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Price Analysis
  5.5.4 Southeast Asia 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Share Analysis
5.6 India Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Analysis
  5.6.1 India Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Overview
  5.6.2 India 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales Price Analysis
  5.6.4 India 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Market Share Analysis

6 GLOBAL 2011-2016E RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales by Type
6.2 Different Types Recombinant Human Granulocyte Colony-stimulating Factor Injection Product Interview Price Analysis
6.3 Different Types Recombinant Human Granulocyte Colony-stimulating Factor Injection Product Driving Factors Analysis
  6.3.1 Non-glycosylated Recombinant Human Granulocyte Colony-stimulating Factor Injection Growth Driving Factor Analysis
  6.3.2 Glycosylated Recombinant Human Granulocyte Colony-stimulating Factor Injection Growth Driving Factor Analysis
  6.3.3 Others Recombinant Human Granulocyte Colony-stimulating Factor Injection Growth Driving Factor Analysis

7 GLOBAL 2011-2016E RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
  7.3.1 Hospital use Recombinant Human Granulocyte Colony-stimulating Factor Injection Growth Driving Factor Analysis
  7.3.2 Clinic use Recombinant Human Granulocyte Colony-stimulating Factor Injection Growth Driving Factor Analysis
  7.3.3 Others Recombinant Human Granulocyte Colony-stimulating Factor Injection Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION

8.1 Jiangsu Wuzhong Pharma
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Jiangsu Wuzhong Pharma 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Jiangsu Wuzhong Pharma 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.2 Johnson & Johnson
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Johnson & Johnson 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Johnson & Johnson 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.4 Kyowa Hakko Kirin Co.,Ltd.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Kyowa Hakko Kirin Co.,Ltd. 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Kyowa Hakko Kirin Co.,Ltd. 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.5 Intas Pharmaceuticals
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Intas Pharmaceuticals 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Intas Pharmaceuticals 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.6 Beijing Sihuan
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Beijing Sihuan 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Beijing Sihuan 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.7 Qilu Pharma
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Qilu Pharma 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Qilu Pharma 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.8 Shandong Kexing
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 Shandong Kexing 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Shandong Kexing 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.9 Teva Pharmaceutical
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
  8.9.3 Teva Pharmaceutical 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Teva Pharmaceutical 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.10 CSPC Baike
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
  8.10.3 CSPC Baike 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 CSPC Baike 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.11 Oversease Manufacturer Company
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
  8.11.3 Oversease Manufacturer Company 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Oversease Manufacturer Company 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
8.12 Shenzhen Xinpeng
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
  8.12.3 Shenzhen Xinpeng 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 Shenzhen Xinpeng 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
Beijing Sihuan
.1 Company Profile
.2 Product Picture and Specifications
.3 Beijing Sihuan 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Beijing Sihuan 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
Xiamen Tebao
.1 Company Profile
.2 Product Picture and Specifications
.3 Xiamen Tebao 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Xiamen Tebao 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
NCPC Jintan
.1 Company Profile
.2 Product Picture and Specifications
.3 NCPC Jintan 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 NCPC Jintan 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis
Beijing Shuanglu
.1 Company Profile
.2 Product Picture and Specifications
.3 Beijing Shuanglu 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Sales, Ex-factory Price, Revenue, Gross Margin Analysis
.4 Beijing Shuanglu 2015 Recombinant Human Granulocyte Colony-stimulating Factor Injection Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 North America 2016-2021 Recombinant Human Granulocyte Colony-stimulating Factor Injection Consumption Forecast
  9.2.2 Europe 2016-2021 Recombinant Human Granulocyte Colony-stimulating Factor Injection Consumption Forecast
  9.2.3 Japan 2016-2021 Recombinant Human Granulocyte Colony-stimulating Factor Injection Consumption Forecast
  9.2.4 China 2016-2021 Recombinant Human Granulocyte Colony-stimulating Factor Injection Consumption Forecast
  9.2.5 Southeast Asia 2016-2021 Recombinant Human Granulocyte Colony-stimulating Factor Injection Consumption Forecast
  9.2.6 India 2016-2021 Recombinant Human Granulocyte Colony-stimulating Factor Injection Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION MARKETING MODEL ANALYSIS

10.1 Recombinant Human Granulocyte Colony-stimulating Factor Injection Regional Marketing Model Analysis
10.2 Recombinant Human Granulocyte Colony-stimulating Factor Injection International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Recombinant Human Granulocyte Colony-stimulating Factor Injection by Regions
10.4 Recombinant Human Granulocyte Colony-stimulating Factor Injection Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION

12.1 New Project SWOT Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection
12.2 New Project Investment Feasibility Analysis of Recombinant Human Granulocyte Colony-stimulating Factor Injection

13 CONCLUSION OF THE GLOBAL RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR INJECTION MARKET PROFESSIONAL SURVEY REPORT 2016